Works matching Eye infections and disorders


Results: 48
    2
    3
    4

    309 Tralokinumab demonstrated a consistent safety profile with up to 42 months of treatment in moderate-to-severe atopic dermatitis: including adverse events of special interest.

    Published in:
    British Journal of Dermatology, 2023, v. 188, p. ii6, doi. 10.1093/bjd/ljac140.009
    By:
    • Reich, Kristian;
    • Simpson, Eric;
    • Langley, Richard;
    • Warren, Richard B;
    • Costanzo, Antonio;
    • Hidehisa Saeki;
    • Almgren, Peter;
    • Gjerum, Le;
    • Carlsson, Anna;
    • Gooderham, Melinda;
    • Pinter, Andreas;
    • De Bruin Weller, Marjolein;
    • Blauvelt, Andrew
    Publication type:
    Article
    5
    6
    7
    8

    Update on Pediatric Atopic Dermatitis.

    Published in:
    Cutis, 2020, v. 106, n. 3, p. 143, doi. 10.12788/cutis.0077
    By:
    • Tracy, Alexis;
    • Bhatti, Safiyyah;
    • Eichenfield, Lawrence F.
    Publication type:
    Article
    9
    10

    Oral Snake Skin Resulting in Anaphylaxis: How and Why?

    Published in:
    Journal of Academic Emergency Medicine Case Reports / Akademik Acil Tip Olgu Sunumlari Dergisi, 2020, v. 11, n. 4, p. 95, doi. 10.33706/jemcr.786358
    By:
    • DÖNMEZ, Ezgi;
    • GÜRSOY, Canan;
    • DÖNMEZ, Cem;
    • GÜMÜŞ DEMİRBİLEK, Semra
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    颞下切除岩尖部肿瘤手术的疗效.

    Published in:
    Journal of Clinical Neurosurgery / Linchuang Shenjingwaike Zazhi, 2020, v. 17, n. 3, p. 298, doi. 10.3969/j.issn.1672-7770.2020.03.012
    By:
    • 虞晨;
    • 戴宇翔;
    • 倪红斌;
    • 张庆荣
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    649 - Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials.

    Published in:
    British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.028
    By:
    • Reich, Kristian;
    • Langley, Richard G;
    • Silvestre, Juan Francisco;
    • Staumont-Salle, Delphine;
    • Costanzo, Antonio;
    • Pink, Andrew;
    • Paller, Amy;
    • Katoh, Norito;
    • Wollenberg, Andreas;
    • Warren, Richard B;
    • Øland, Christian Bjerregård;
    • Tindberg, Ann-Marie;
    • Gjerum, Le;
    • Simpson, Eric
    Publication type:
    Article
    45

    Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials.

    Published in:
    British Journal of Dermatology, 2024, v. 190, p. ii52, doi. 10.1093/bjd/ljad498.054
    By:
    • Reich, Kristian;
    • Langley, Richard G.;
    • Silvestre, Juan Francisco;
    • Staumont-Salle, Delphine;
    • Costanzo, Antonio;
    • Pink, Andrew;
    • Paller, Amy;
    • Katoh, Norito;
    • Wollenberg, Andreas;
    • Warren, Richard B.;
    • Øland, Christian Bjerregård;
    • Tindberg, Ann-Marie;
    • Gjerum, Le;
    • Simpson, Eric
    Publication type:
    Article
    46
    47
    48